The Articles of Association state that the Board of Directors may have no less than three and no more than eighteen members, serving for a term of four years.
The Company is currently run by a Board of Directors with seven members, whose Chairman is Doctor Jean-Claude MARIAN.
| Member | Term ends |
| Doctor Jean-Claude MARIAN | 2015 general meeting |
| Yves LE MASNE | 2015 general meeting |
| Brigitte MICHEL | 2013 general meeting |
| Alexandre MALBASA | 2013 general meeting |
| Jean-Patrick FORTLACROIX | 2014 general meeting |
| FFP Invest represented by Thierry MABILLE de PONCHEVILLE | 2015 general meeting |
| NEO GEMA represented by Philippe AUSTRUY | 2015 general meeting |
The offices of Chairman and Chief Executive Officer are separated.
Yves Le Masne is ORPEA's Chief Executive Officer, and Doctor Jean-Claude Marian is Chairman of the Board.
The Board of Directors has set up two committees:
Audit Committee
The Audit Committee monitors issues relating to the drawing up and control of accounting and financial information, in order to prepare the Board of Directors’ decisions with regards to financial and accounting matters. The members of the Audit Committee are:
Appointments and Remuneration Committee
The main mission of the Appointments and Remuneration Committee is notably to inform the Board of Directors’ decisions regarding General Management procedures and the status of its executives, and to submit proposals to the Board regarding the choice of Directors. The members of the Appointments and Remuneration Committee are: